Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Divi's Laboratories Limited (NSE: DIVISLAB), ISIN INE361B01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
DIVISLAB last traded at ₹9596.75 (+2.70%), with a 52-week range of ₹5637.50 to ₹10000.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 51.88%, FIIs 20.20%, DIIs 19.38%, mutual funds 13.87%.
EquiSense Score (ECS): 81/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.